RxDoctor Payments Data

Ryan Ahern

Internal Medicine · Seattle, WANPI 1457615825

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 73.6% of it on its own, with 1 other manufacturer making up the rest.

$92in general payments, 2019–2025

Across 2 payments — averaging $46.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$68
  • Pfizer$24
$7,298,494in research payments, 2019–2025

Across 2 payments — averaging $3,649,247 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$7.3M

What the payments were for

  • Food & beverage$92100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific1$68
Pfizer1$24

How this compares

$92 in reported general payments places this provider in the 60th percentile of 2,038 internal medicine providers in Washington.

See all internal medicine providers in Washington

Other internal medicine in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →